Expression and characterization of tissue inhibitor of metalloproteinase 4 from complex canine mammary carcinomas
- 16 March 2016
- journal article
- research article
- Published by Taylor & Francis in Journal of Immunoassay and Immunochemistry
- Vol. 37 (5) , 515-526
Abstract
All four members of the tissue inhibitors of metalloproteinase (TIMP) family have been reported to be over-expressed in breast cancer cells in vitro. Dysregulation of TIMP-4 expression predicts poor prognosis in cancers. The present study evaluated the association of the expression levels of TIMP-4 with mammary tumor development in dogs, measured by real-time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). Mammary tissue samples were collected from healthy canine mammary gland and from tumor subjects. TIMP-4 expression was found to be upregulated (5.856 times) in complex canine mammary carcinomas. Also, TIMP-4 mature peptide was expressed heterologously in E. coli. The recombinant protein was purified by Ni- NTA affinity chromatography and further confirmed by western blotting. The rTIMP-4 was found to be functionally active and could inhibit matrix metalloproteinase 11(MMP-11) activity. Immunization of mice with rTIMP-4 resulted in increased antigen specific serum antibody titer, and this serum could be suitably used to detect and quantify the protein in sera of dogs with mammary tumors. TIMP-4 could act as a marker of canine mammary tumors. To the best of our knowledge, this is the first report of heterologous expression of TIMP-4 from complex canine mammary carcinomas.Keywords
Funding Information
- Department of Biotechnology, Ministry of Science and Technology (BT/PR6434/GBD/27/414/2012)
This publication has 20 references indexed in Scilit:
- Identification of single nucleotide polymorphism in stromelysin-3 catalytic domain in canine mammary tumoursJournal of Applied Animal Research, 2013
- Mice with Tissue Inhibitor of Metalloproteinases 4 (Timp4) Deletion Succumb to Induced Myocardial Infarction but Not to Cardiac Pressure OverloadJournal of Biological Chemistry, 2010
- Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literatureBMC Cancer, 2009
- Genetic lines differ in Toll-like receptor gene expression in spleens of chicks inoculated with Salmonella enterica serovar EnteritidisPoultry Science, 2009
- Tissue Inhibitor of Metalloproteinases-4. The road less traveledMolecular Cancer, 2008
- Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinomaLaboratory Investigation, 2007
- Histological Grading and Prognosis in Dogs with Mammary Carcinomas: Application of a Human Grading MethodJournal of Comparative Pathology, 2005
- Increase in the ratio of matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 in saliva from patients with primary Sjögren's syndromeClinica Chimica Acta, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Molecular Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinase 4Journal of Biological Chemistry, 1996